SLC1A2 and essential thrombocythemia: Due to the overlap phenomena between ET and PD, investigations into the relationship between PD risk variants and ET patients have been done, involving LINGO1, LINGO2, LRRK2, SLC1A2, and HTRA2 genes [3, 10–12].